SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
                                 ---------------

                                    FORM 10-Q

(Mark One)

 ___              QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d)
/ X /             OF THE SECURITIES EXCHANGE ACT OF 1934
- ----


For the quarterly period ended September 30, 1999

                                       OR

 ___             TRANSITION REPORT PURSUANT TO SECTION 13 OR 15 (d)
/   /            OF THE SECURITIES EXCHANGE ACT OF 1934
- ----


For the transition period from                        to
                                --------------------       --------------------

                         Commission file number 1-10258

                              Tredegar Corporation
- -------------------------------------------------------------------------------
             (Exact Name of Registrant as Specified in its Charter)

  Virginia                                                 54-1497771
- -------------------------------                  -------------------------------
(State or Other Jurisdiction of                         (I.R.S. Employer
 Incorporation or Organization)                         Identification No.)

1100 Boulders Parkway
Richmond, Virginia                                           23225
- ---------------------------------------          ------------------------------
(Address of Principal Executive Offices)                    (Zip Code)

Registrant's telephone number, including area code:  (804) 330-1000

        Indicate  by check  whether  the  registrant  (1) has filed all
reports  required  to be filed by  Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter
period that the  registrant  was required to file such reports), and (2) has
been subject to such filing requirements for the past 90 days.
Yes        X      No
          -----       -----

        The number of shares of Common Stock, no par value, outstanding as of
October 31, 1999:  37,261,900.





PART I - FINANCIAL INFORMATION

Item 1.  Financial Statements.



                    Tredegar Corporation
                 Consolidated Balance Sheets
                       (In Thousands)
                         (Unaudited)


                                                              Sept. 30,      Dec. 31,
                                                                1999           1998
                                                              --------       --------
                                                                      
Assets
Current assets:
    Cash and cash equivalents                                 $ 19,434       $ 25,409
    Accounts and notes receivable                              118,962         94,341
    Inventories                                                 46,264         34,276
    Deferred income taxes                                        8,755          8,762
    Prepaid expenses and other                                   2,085          3,536
      Total current assets                                     195,500        166,324
Property, plant and equipment, at cost                         459,755        356,411
Less accumulated depreciation and amortization                 218,715        200,380
      Net property, plant and equipment                        241,040        156,031
Venture capital investments                                    107,876         60,024
Other assets and deferred charges                               39,955         41,886
Goodwill and other intangibles                                 153,936         32,913
                                                              ---------      ---------
      Total assets                                           $ 738,307      $ 457,178
                                                              =========      =========

Liabilities and Shareholders' Equity

Current liabilities:
    Accounts payable                                         $  61,200      $ 47,551
    Accrued expenses                                            43,604        41,071
    Income taxes payable                                           163           243
                                                              --------      --------
      Total current liabilities                                104,967        88,865
Long-term debt                                                 250,000        25,000
Deferred income taxes                                           25,956        24,914
Other noncurrent liabilities                                     7,997         8,104
                                                              --------      --------
      Total liabilities                                        388,920       146,883
                                                              --------      --------
Shareholders' equity:
    Common stock, no par value                                  98,972        95,893
    Common stock held in trust for savings
      restoration plan                                          (1,212)       (1,212)
    Unrealized gain on available-for-sale security               3,125         1,376
    Foreign currency translation adjustment                     (1,630)       (2,519)
    Retained earnings                                          250,132       216,757
                                                              --------      --------
      Total shareholders' equity                               349,387       310,295
                                                              --------      --------
      Total liabilities and shareholders' equity              $738,307     $ 457,178
                                                              ========      ========



       See accompanying notes to financial statements.

                                       2




                              Tredegar Corporation
                        Consolidated Statements of Income
                                 (In Thousands)
                                   (Unaudited)



                                                 Third Quarter           Nine Months
                                                Ended Sept. 30         Ended Sept. 30
                                              ------------------   ---------------------
                                               1999       1998       1999        1998
                                             --------   --------   --------   ----------
                                                                  
Revenues:

    Net sales                                 $215,911  $186,638   $590,292   $513,244
    Other income (expense), net                 (3,889)     (246)    (4,907)     3,055
                                              --------  --------   --------   --------
      Total                                    212,022   186,392    585,385    516,299
                                              --------  --------   --------   --------

Costs and expenses:
    Cost of goods sold                         171,389   148,223    465,614    405,760
    Selling, general and administrative         11,991     9,892     34,513     28,868
    Research and development                     5,969     3,374     15,819     10,321
    Amortization of intangibles                  1,275        86      2,144        120
    Interest                                     3,047       266      4,853        952
    Unusual items                                 (712)        -      3,916       (765)
                                             ---------  --------   ---------  --------
      Total                                    192,959   161,841    526,859    445,256
                                             ---------  --------   ---------  --------
Income before income taxes                      19,063    24,551     58,526     71,043
Income taxes                                     6,748     8,591     20,723     22,626
                                             ---------  --------   ---------  --------
Income from continuing operations               12,315    15,960     37,803     48,417
Income from discontinued operations                  -     3,421          -      3,421
                                              --------  --------   --------   --------
Net income                                    $ 12,315   $19,381   $ 37,803   $ 51,838
                                              ========   =======   ========   ========

Earnings per share:
    Basic:
      Continuing operations                   $   .33   $   .44   $   1.02   $   1.33
      Discontinued operations                      -        .09          -        .09
                                              -------   -------   --------   --------
      Net income                              $   .33   $   .53   $   1.02   $   1.42
                                              =======   =======   ========   ========
    Diluted:
      Continuing operations                   $   .32   $   .41   $    .97   $   1.24
      Discontinued operations                      -        .09        -          .09
                                              -------   -------   --------   --------
      Net income                              $   .32   $   .50   $    .97   $   1.33
                                              =======   =======   ========   ========

Shares used to compute earnings per share:

    Basic                                      37,098   36,351     36,893     36,483
    Diluted                                    38,718   38,582     38,754     38,966

Dividends per share                            $ .04    $ .04     $   .12    $   .11




                 See accompanying notes to financial statements.

                                       3


                              Tredegar Corporation
                      Consolidated Statements of Cash Flows
                                 (In Thousands)
                                   (Unaudited)



                                                                     Nine Months Ended
                                                                       Ended Sept. 30
                                                                  -------------------------
                                                                    1999             1998
                                                                  ---------       ---------
                                                                            
Cash flows from operating activities:
    Net income                                                    $  37,803       $  51,838
    Adjustments for noncash items:
      Depreciation                                                   20,146          15,897
      Amortization of intangibles                                     2,144             120
      Write-off of in-process R&D acquired and other intangibles     3,725l               -
      Deferred income taxes                                          (1,071)          2,043

      Accrued pension income and postretirement benefit              (2,331)         (2,833)
      Loss (gain) on sale of venture capital investments              4,994          (2,041)
      Loss (gain) on equipment writedowns and divestitures              458            (765)
      Gain related to discontinued operations                             -          (5,346)
      Changes in assets and liabilities, net of
        effects from acquisitions and divestitures:
      Accounts and notes receivable                                 (10,208)         (4,197)
      Inventories                                                     4,806          (2,010)
      Income taxes recoverable                                            -             294
      Prepaid expenses and other                                      1,624             921
      Accounts payable                                               10,502           5,852
      Accrued expenses and income taxes payable                       1,347          (3,144)
    Other, net                                                       (2,117)         (1,870)
                                                                   ---------      ---------
      Net cash provided by operating activities                      71,822          54,759
                                                                   ---------      ---------
Cash flows from investing activities:
    Capital expenditures                                            (32,792)        (24,269)
    Acquisitions (net of cash acquired of $1,097 in
      1998; excludes equity issued of $11,219 in 1998)             (215,227)        (60,883)
    Venture capital investments                                     (55,727)        (27,121)
    Proceeds from the sale of venture capital investment              2,234           2,919
    Proceeds from property disposals and divestitures                   905             740
    Other, net                                                         (841)         (1,140)
                                                                  ---------       ---------
      Net cash used in investing activities                        (301,448)       (109,754)
                                                                  ---------       ---------

Cash flows from financing activities:
    Dividends paid                                                   (4,428)         (3,955)
    Net increase (decrease) in borrowings                           225,000          (5,000)
    Repurchases of Tredegar common stock                               -            (36,460)
    Tredegar common stock purchased by trust for
      savings restoration plan                                         -               (192)
    Proceeds from exercise of stock options (including
      related income tax benefits realized)                           3,079           3,824
                                                                  ---------       ---------
      Net cash provided by (used in) financing activit              223,651         (41,783)
                                                                  ---------       ---------
Increase (decrease) in cash and cash equivalents                    (5,975)         (96,778)
Cash and cash equivalents at beginning of period                    25,409          120,065
                                                                  ---------       ---------
Cash and cash equivalents at end of period                        $ 19,434        $  23,287
                                                                  =========       =========



       See accompanying notes to financial statements.

                                       4



                              TREDEGAR CORPORATION
             NOTES TO THE CONSOLIDATED INTERIM FINANCIAL STATEMENTS
                                   (Unaudited)


1.       In the opinion of management,  the accompanying  consolidated financial
         statements  of  Tredegar  Corporation  and  Subsidiaries   ("Tredegar")
         contain all adjustments  necessary to present  fairly,  in all material
         respects,  Tredegar's  consolidated  financial position as of September
         30, 1999, and the consolidated results of operations and cash flows for
         the nine months ended September 30, 1999 and 1998. All such adjustments
         are  deemed  to  be  of a  normal  recurring  nature.  These  financial
         statements   should  be  read  in  conjunction  with  the  consolidated
         financial  statements and related notes  included in Tredegar's  Annual
         Report on Form 10-K for the year ended  December 31, 1998.  The results
         of operations  for the nine months ended  September  30, 1999,  are not
         necessarily indicative of the results to be expected for the full year.

2.       On October 20, 1999,  Tredegar  borrowed  $250 million under a new term
         loan  agreement  dated  October  13,  1999.  A portion of the term loan
         proceeds  ($230  million)  was  used to  repay  all of the  outstanding
         borrowings  under our  revolving  credit  facility.  The  balance  ($20
         million) was invested in cash  equivalents,  and is expected to be used
         in the next  twelve  months to fund  capital  expenditures  and venture
         capital investment opportunities. The revolving credit facility permits
         borrowings  of up to $275 million (no amounts  borrowed at November 12,
         1999) and  matures on July 9, 2002.  Tredegar  also has a note  payable
         with a remaining balance of $20 million. Total debt due and outstanding
         at November 12, 1999 is summarized below:


                    Debt Due and Outstanding at Nov. 12, 1999
                    -----------------------------------------
                             (Dollars in Thousands)

                                                          Total
                         Year       Note      Term        Debt
                         Due      Payable     Loan        Due
                       --------   -------   --------   --------
                         2000     $ 5,000   $   -      $  5,000
                         2001       5,000       -         5,000
                         2002       5,000       -         5,000
                         2003       5,000     50,000     55,000
                         2004          -      75,000     75,000
                         2005          -     125,000    125,000
                         ---------------------------------------
                         Total    $20,000   $250,000   $270,000

                                       5


                  Interest  is  payable  on the note  semi-annually  at 7.2% per
         year.  The term  loan  and  revolving  credit  agreements  provide  for
         interest to be charged at a base rate  (generally the London  Interbank
         Offered  Rate  ("LIBOR"))  plus  a  spread  that  is  dependent  on our
         quarterly debt-to-total capitalization ratio. The fully-borrowed spread
         over LIBOR charged at the various  debt-to-total  capitalization levels
         are as follows:


                        Fully-Borrowed Spread Over LIBOR
                     Under Credit Agreements (Basis Points)
                     --------------------------------------
        Debt-to-Total                                                  Term
        Capitalization Ratio                                Revolver   Loan
        --------------------                                --------   -----

        Greater than 55% and less than or equal to 60%       50.0      100.0
        Greater than 50% and less than or equal to 55%       50.0       87.5
        Greater than 40% and less than or equal to 50%       37.5       75.0
        Greater than 35% and less than or equal to 40%       37.5       62.5
        Greater than 30% and less than or equal to 35%       30.0       62.5
        Less than or
         equal to    30%                                     30.0       50.0


                  The interest rate on the $250 million term loan for the 92-day
         period from October 20, 1999 to January 20, 2000, is 7%, and will float
         thereafter  based  on the  interest  period  selected,  LIBOR  and  the
         applicable  spread over  LIBOR.  Our loan  agreements  permit a maximum
         debt-to-total capitalization ratio of 60%.

3.       On September 24, 1999, Tredegar announced that its board of directors
         is evaluating alternative financing and structural options for its
         technology group, including a possible spin-off of the unit into an
         independent company. The technology group was formed in 1992 and
         includes Molecumetics, Ltd.,Therics, Inc. and Tredegar Investments,
         Inc.  Molecumetics, based in Seattle, Washington, is a drug discovery
         company dedicated to the identification of small-molecule drug
         candidates for license and development by pharmaceutical and
         biotechnology company partners, which currently include Bristol-Myers
         Squibb Company, Asahi Chemical Industries, Teijin Limited, ChoongWae
         Pharma and Pharmacia & Upjohn Company.  Therics, based in Princeton,
         New Jersey, was acquired on April 8, 1999 (see Note 4), and is
         developing microfabrication technology that has potential applications
         in drug delivery and other medical markets.  Tredegar Investments,
         also based in Seattle, is our venture capital subsidiary.

                The carrying value of venture  capital  investments was $107.9
         million($110.1  million  cost basis) at September  30, 1999,  and $60
         million  ($60.6 million cost basis) at December 31, 1998. The estimated
         net asset value of venture  capital  investments  at September 30, 1999
         and December 31, 1998, were as follows:




                                                    (In Thousands Except Per-Share Data)
                                                            Sept. 30,         Dec. 31,
                                                              1999              1998

                                                                       
Estimated fair value of venture capital investments       $138,514           $ 70,841
Estimated income taxes on assumed disposal at
    fair value                                             (10,221)            (3,681)
                                                          --------           --------
Net asset value of venture capital investments            $128,293           $ 67,160
                                                          ========           ========
Net asset value of venture capital investments
    per Tredegar common share                             $   3.45           $   1.83
                                                          ========           ========

                                       6


                  The change in net asset value for venture capital  investments
         related to investment activities and portfolio performance for the nine
         months ended September 30, 1999 and 1998, is summarized below:




                                                                    (In Thousands)
                                                                     Nine Months
                                                                    Ended Sept. 30
                                                                   1999       1998
                                                                 ---------  ---------
                                                                       
    Net realized gains, losses, writedowns and related
      operating expenses for venture capital investments
      reflected in consolidated statements of income             $ (6,767)   $ 1,104
    Change in unrealized appreciation of venture
      capital investments                                          22,554     (5,608)
    Pretax change in venture capital net asset value
      related to investment activities                             15,787     (4,504)
    Provision for income taxes                                      5,683     (1,621)
    Net change in venture capital net asset value
      related to investment activities                           $ 10,104    $(2,883)



                  The venture  capital  portfolio is comprised of investments in
         private  venture  capital fund  limited  partnerships  and  early-stage
         technology  companies,  including the stock of privately held companies
         and the  restricted  and  unrestricted  stock of  companies  that  have
         recently  merged with other public  companies or  registered  shares in
         initial public  offerings.  As a result of these  investments,  we have
         direct or indirect  ownership stakes in more than 150  technology-based
         start-up  companies,  primarily  in  the  communications,   information
         technology and life sciences  industries.  The portfolio has an overall
         weighted average age of 1.6 years.  Most liquidation  opportunities are
         not  expected  for  several  years  and will  depend  on many  factors,
         including market conditions.

                  The fair value of securities of public companies is determined
         based on  closing  price  quotations.  We  estimate  the fair  value of
         securities of private  companies  using the  indicative  value from the
         latest round of financing,  and reduce this amount if events subsequent
         to the financing imply a lower  valuation.  The fair value of ownership
         interests in private  venture capital funds is based on our estimate of
         our distributable  share of fund net assets using the general partners'
         estimate  of fair  value  of  securities  held by the  funds  and  fund
         formulas for allocating profits,  losses and distributions.  Because of
         the inherent  uncertainty  associated  with the valuation of restricted
         securities or securities for which there is no public market, estimates
         of fair value may differ  significantly  from the value that would have
         been used had a ready market for the securities existed.

4.       On May 17,  1999,  Tredegar  acquired  the  assets  of  Exxon  Chemical
         Company's plastic films business ("Exxon Films") for cash consideration
         of approximately $205 million (including estimated transaction costs of
         $2.9 million).  The acquisition  was funded with  borrowings  under our
         revolving  credit  facility,  and has since been  refinanced by our new
         term loan (see Note 2).  During  the 12 months  ended  March 31,  1999,
         Exxon Films had pro forma  revenues of $111 million and  generated  pro
         forma  EBITDA  (earnings  before  interest,   taxes,  depreciation  and
         amortization and excluding potential  synergies) of $24.6 million.  The
         asset-purchase structure, unlike a stock-purchase  transaction,  allows
         Tredegar  to  deduct  for tax  purposes  over  time the  full  value of
         depreciable fixed assets and intangibles (goodwill).

                                       7


                  Tredegar  expects that, by 2001, the annual  ongoing  benefits
         from   synergies   (cost   reductions,   efficiencies   and  technology
         enhancements expected from the integration of Exxon Films into existing
         operations) will range from $7 - $9 million.

                  In addition to Exxon Films, Tredegar acquired:

- -        The assets of Therics, Inc. ("Therics") on April 8, 1999
- -        The stock of Canadian-based Exal Aluminum Inc. ("Exal") on June 11,1998
- -        Two Canadian-based aluminum extrusion and fabrication plants from
         Reynolds Metals Company ("Reynolds") on February 6, 1998

                  The assets of Therics were acquired for cash  consideration of
         $13.6 million (including  transaction  costs).  Before the acquisition,
         Tredegar owned approximately 19% of Therics. Upon the final liquidation
         of the former  Therics,  Tredegar  will have paid  approximately  $10.2
         million to  effectively  acquire the remaining 81% ownership  interest.
         Tredegar  recognized a nonrecurring  charge of $3.5 million (classified
         in  unusual  items in the  consolidated  statements  of  income) in the
         second quarter of 1999 related to the write-off of acquired  in-process
         research  and  development.  The amount of the  charge  was  determined
         through an independent, third-party analysis.

                  Exal was acquired  for $44.1  million  (including  transaction
costs), which was comprised of:

- -        Cash consideration of $32.9 million($31.8 million net of cash acquired)
         380,172 shares of Class I non-voting preferred shares of Tredegar's Bon
         L Canada subsidiary (the "Class I Shares")

                  The Class I Shares are  exchangeable  into  shares of Tredegar
         common stock on a one-for-one basis. Each Class I Share is economically
         equivalent  to one  share of  Tredegar  common  stock  and  accordingly
         accounted for in the same manner.  Tredegar  funded the cash portion of
         the purchase price with available cash on hand. Exal operates  aluminum
         extrusion  plants in  Pickering,  Ontario  and  Aurora,  Ontario.  Both
         facilities  manufacture  extrusions for  distribution,  transportation,
         electrical,  machinery  and  equipment,  and building and  construction
         markets.  The Pickering facility also produces aluminum logs and billet
         for internal use and for sale to customers.

                  The former  Reynolds  plants in Canada were  acquired for cash
         consideration  of $29.1  million  (including  transaction  costs) using
         available cash on hand. The plants are located in Ste-Therese,  Quebec,
         and Richmond Hill, Ontario.  Both facilities  manufacture  extruded and
         fabricated   aluminum   products   used   primarily   in  building  and
         construction,  transportation, electrical, machinery and equipment, and
         consumer durables markets.

                                        8

                  Each  acquisition was accounted for using the purchase method,
         and  related   operating  results  have  been  included  in  Tredegar's
         consolidated  statements of income since the dates  acquired.  Detailed
         pro forma financial  information for these  acquisitions  through March
         31,  1999,  were  included  in our Form 8-K/A  filed on June 25,  1999.
         Selected  historical and pro forma  financial  information for Tredegar
         through September 30, 1999, is as follows:



                              Tredegar Corporation
             Selected Historical and Pro Forma Financial Information
                     (In Thousands Except Per-Share Amounts)


                                                   Third Quarter       Nine Months    Last 12
                                                   Ended Sept. 30    Ended Sept. 30    Months
                                                   1999     1998      1999     1998    9/30/99
                                                 -------- --------- -------- -------- ---------
                                                                       
Net sales:
    Manufacturing operations                     $214,190 $ 185,318 $584,806 $509,228 $ 769,627
    Technology operating companies                  1,721     1,320    5,486    4,016     7,217

Net income:
    Manufacturing operations                     $ 16,496 $  16,990 $ 48,588 $ 46,792 $  65,733
    Technology Group:
      Operating companies                          (1,808)     (635)  (3,948)  (1,848)   (4,616)
      Venture capital investments                  (2,829)     (395)  (4,331)     707    (4,644)
    Unusual items                                     456         -   (2,506)   2,766    (2,931)
    Discontinued operations                             -     3,421        -    3,421     1,292
                                                 -------- --------- -------- -------- ---------
      Total                                      $ 12,315 $  19,381 $ 37,803 $ 51,838 $  54,834
                                                 ======== ========= ======== ======== =========

Diluted earnings per share:
    Manufacturing operations                     $    .43 $     .44 $   1.25 $   1.20 $    1.70
    Technology Group:
      Operating companies                            (.05)     (.02)    (.10)    (.05)     (.12)
      Venture capital investments                    (.07)     (.01)    (.11)     .02      (.12)
    Unusual items                                     .01         -     (.07)     .07      (.07)
    Discontinued operations                             -       .09        -      .09       .03
                                                 -------- --------- -------- -------- ---------
      Total                                      $    .32 $     .50 $    .97 $   1.33 $    1.42
                                                 ======== ========= ======== ======== =========

EBITDA - manufacturing operations                $ 36,464 $  31,547 $ 99,711 $ 86,317 $ 132,043
    As a % of related net sales                     17.0%     17.0%    17.1%    17.0%     17.2%
Loss before deprec. & amortiz. for
    technology operating companies                 (2,085)     (732)  (4,269)  (2,136)   (4,805)
================================================================================================
Consolidated pro forma information for
    acquisitions as if they had occurred
    at the beginning of 1998:
    Net sales:
      Manufacturing operations                   $214,190 $ 212,669 $628,075 $632,753 $ 841,141
      Tech. operating companies                     1,721     1,344    5,512    4,056     7,268
    EBITDA - manufacturing oper.                   36,464    37,721  109,185  104,950   147,319
      As a % of pro forma net sales                 17.0%     17.7%    17.4%    16.6%     17.5%
    Loss before deprec. & amortiz. for
      tech. operating companies                    (2,085)   (2,600)  (6,061)  (7,638)   (8,589)
    Manufacturing operations:
      Net income                                   16,496    16,936   48,770   45,340    65,629
      Diluted earnings per share                      .43       .44     1.26     1.15      1.69
    Technology operating companies:
      Net loss                                     (1,808)   (2,160)  (5,455)  (6,308)   (7,764)
      Diluted loss per share                         (.05)     (.06)    (.14)    (.16)     (.20)



                                       9




                  Pro forma results  assume that Tredegar made the  acquisitions
         at the  beginning  of 1998.  Excluded  from the pro forma  results  are
         synergies  expected  from the  integration  of  acquired  and  existing
         operations.  Accordingly,  the pro forma financial information does not
         purport  to be  indicative  of the  future  results  or  the  financial
         position  of  Tredegar or the net income and  financial  position  that
         would  actually  have  been  attained  had the pro  forma  transactions
         occurred on the dates or for the periods indicated.

                  Unusual items in 1999 include:

         -   A  third-quarter  gain  of  $712,000  on the sale of corporate real
             estate ($456,000 after income taxes)
         -   A  second  quarter  charge  of  $3.5  million  for the write-off of
             in-process  R&D  related  to  the Therics acquisition ($2.2 million
             after deferred income tax benefits)
         -   A  second  quarter  charge  of  $1.2  million  for the write-off of
             equipment related to excess packaging film capacity ($749,000 after
             income tax benefits)

                  Unusual items in 1998 include a  first-quarter  pretax gain of
         $765,000 on the sale of APPX  Software.  Income taxes in 1998 include a
         tax benefit of $2 million related to the sale,  including a tax benefit
         for the excess of APPX  Software's  income tax basis over its financial
         reporting basis.  Discontinued  operations in 1998 include an after-tax
         gain of $3.4 million  related to the  reversal of an accrued  liability
         that we established to cover future payments to the United Mine Workers
         of America  Combined  Benefit Fund. We were relieved of this liability,
         which was incurred by the divested coal business.

5.       Comprehensive  income,  defined as net  income and other  comprehensive
         income, was $14 million for the third quarter of 1999 and $10.7 million
         for the third quarter of 1998.  Comprehensive  income was $40.4 million
         for the first nine months of 1999 and $44.5  million for the first nine
         months  of  1998.  Other  comprehensive   income  includes  changes  in
         unrealized  gains  and  losses  on  available-for-sale  securities  and
         foreign  currency  translation  adjustments  recorded  net of  deferred
         income taxes directly in shareholders' equity.

6. The components of inventories are as follows:

                                                     (In Thousands)

                                              Sept. 30            Dec. 31
                                                1999               1998
                                            --------------     --------------
         Finished goods                            $8,130             $4,805
         Work-in-process                            4,202              3,751
         Raw materials                             24,276             17,690
         Stores, supplies and other                 9,656              8,030
                                            --------------     --------------
             Total                                $46,264            $34,276
                                            ==============     ==============


                                       10



7.       Basic  earnings  per share is computed  by  dividing  net income by the
         weighted average number of shares of common stock outstanding.  Diluted
         earnings  per share is computed by dividing  net income by the weighted
         average  common  and  potentially  dilutive  common  equivalent  shares
         outstanding, determined as follows:




                                                               (In Thousands)

                                                       Third Quarter       Nine Months
                                                       Ended Sept. 30    Ended Sept. 30
                                                      ----------------   ---------------
                                                       1999      1998     1999     1998
                                                      ------    ------   ------   ------
                                                                      
Weighted average shares outstanding used
    to compute basic earnings per share               37,098    36,351   36,893   36,483
Incremental shares issuable upon the
    assumed exercise of stock options                  1,620     2,231    1,861    2,483
                                                      ------    ------   ------   ------
Shares used to compute diluted earnings
    per share                                         38,718    38,582   38,754   38,966
                                                      ======    ======   ======   ======



                  Incremental  shares  issuable  upon the  assumed  exercise  of
         outstanding  stock options are computed  using the average market price
         during the related period.

8.       The  Financial  Accounting  Standards  Board has issued a new  standard
         affecting  the  accounting  for  derivative   instruments  and  hedging
         activities.  This standard is not expected to significantly  change our
         operating results, financial condition or disclosures. The new standard
         will be adopted in the first quarter of 2001.


                                       11


Item 2.  Management's Discussion and Analysis of Financial Condition and Results
         of Operations.

                              Results of Operations

               Third Quarter 1999 Compared with Third Quarter 1998

         Financial  results for the quarter and  year-to-date  are summarized on
page 9.

         Earnings  from  manufacturing  operations  decreased  to 43  cents  per
diluted  share in the third  quarter of 1999 from 44 cents per diluted  share in
1998.  Excluding  the results from the plastic  films  operations  acquired from
Exxon  Chemical  Company (see Note 4 on page 7),  profits in our films  business
declined and continue to be adversely  affected by lower volume,  higher product
development  costs,  delays  in  new  product   introductions  and  weakness  in
international  markets.  Profits were up 4% in the company's  aluminum extrusion
business as continued  volume  growth was  partially  offset by higher  aluminum
costs.

         On September 24, 1999,  Tredegar  announced that its board of directors
is evaluating  alternative  financing and structural  options for its technology
group,  including a possible  spin-off of the unit into an independent  company.
See Note 3 on page 6 for more information.

         Third-quarter  1999 net sales increased  primarily due to acquisitions.
On a pro forma basis,  net sales  increased by 1% due to higher volume and sales
from the plastic films plants acquired from Exxon and higher volume and sales in
Aluminum Extrusions.

         The  consolidated  gross profit margin during the third quarter of 1999
and 1998 was 20.6%.

         Selling,  general  and  administrative  (SG&A)  expenses  in the  third
quarter of 1999 were $12 million,  up from $9.9 million in 1998 due primarily to
acquisitions  and  higher  spending  on new  products  in  Film  Products.  As a
percentage of sales, SG&A expenses  increased to 5.6% in 1999 compared with 5.3%
in 1998.

         Research and development  expenses increased by $2.6 million or 77% due
to the acquisition of Therics and higher spending at Molecumetics.

         Interest income, which is included in "Other income (expense),  net" in
the consolidated  statements of income,  increased slightly in the third quarter
of 1999 (up $92,000).  The average tax-equivalent yield earned was approximately
5.1% in 1999 and 5.6% in 1998. Interest expense increased by $2.8 million due to
funds borrowed on a floating-rate  basis under our revolving  credit facility to
acquire  Exxon  Films  (see  Note 2 on page 5 and Note 4 on page  7),  partially
offset  by  higher   capitalized   interest   resulting   from  higher   capital
expenditures.  Average  debt  outstanding  during the third  quarter  was $238.6
million (including average floating-rate debt outstanding of $218.6 million), up
from $25 million (all 7.2%  fixed-rate  debt) in the third quarter of last year.
The average  interest  rate on debt declined to 5.7% during the third quarter of
1999 from 7.2% in 1998 due to a higher  proportion of  floating-rate  debt.  The
average  interest  rate on  floating-rate  debt in the third quarter of 1999 was
5.6% (the rate as of November 12, 1999, was 7% - see Note 2 on page 5).

                                       12


         The effective tax rate  excluding  unusual items  increased to 35.4% in
the third quarter of 1999 from 35% in the third quarter of 1998.

                 Nine Months 1999 Compared with Nine Months 1998

         The improved  earnings from  manufacturing  operations during the first
nine months  ($1.25 per diluted  share in 1999 versus $1.20 per diluted share in
1998) were driven by higher volume and  acquisitions in our aluminum  extrusions
business and the  acquisition  of Exxon Films (see Note 4 on page 7).  Excluding
the results from the plastic films  operations  acquired from Exxon,  profits in
the films  business  declined  and  continue to be  adversely  affected by lower
volume,  higher product development costs,  delays in new product  introductions
and weakness in international markets. See Note 3 on page 6 regarding our recent
announcement concerning the technology group.

         Net  sales  for  the  first  nine  months  of  1999  increased  due  to
acquisitions.  On a pro forma basis,  net sales  declined by less than 1% due to
lower average selling prices in Film Products and Aluminum Extrusions, partially
offset by higher pro forma  volume in Film  Products and higher pro forma volume
and sales in Aluminum  Extrusions.  Lower selling  prices  reflect lower average
plastic  resin and aluminum  costs.  Higher  volume on a pro forma basis in Film
Products was due to the plastic films operations acquired from Exxon.

         The consolidated  gross profit margin for the first nine months of 1999
increased to 21.1% from 20.9% in 1998.

         Selling,  general and administrative (SG&A) expenses were $34.5 million
in 1999, up from $28.9 million in 1998 due primarily to acquisitions  and higher
spending on new  products  in Film  Products.  As a  percentage  of sales,  SG&A
expenses increased to 5.8% in 1999 compared with 5.6% in 1998.

         Research and development  expenses increased by $5.5 million or 53% due
to the acquisition of Therics and higher spending at Molecumetics.

         Interest income, which is included in "Other income (expense),  net" in
the consolidated statements of income,  decreased by $1.1 million due to a lower
average cash  equivalents  balance (see Liquidity and Capital  Resources on page
16) and lower yields. The average  tax-equivalent yield earned was approximately
4.9% in 1999 and 5.7% in 1998. Interest expense increased by $3.9 million due to
funds borrowed on a floating-rate  basis under our revolving  credit facility to
acquire  Exxon Films (see Note 2 on page 5 and Note 4 on page 7).  Average  debt
outstanding  during the first nine months of 1999 was $130.8 million  (including
average floating-rate debt outstanding of $107.8 million), up from $28.1 million
(all 7.2% fixed-rate debt) last year. The average interest rate on debt declined
to 5.8% in 1999 from 7.2% in 1998 due to a higher  proportion  of  floating-rate
debt. The average interest rate on floating-rate debt in 1999 was 5.5% (the rate
as of November 12, 1999, was 7% - see Note 2 on page 5).

         The effective tax rate  excluding  unusual items  increased to 35.4% in
the first nine months of 1999 from 35% in 1998 due to lower tax exempt income.

                                       13




                                 Segment Results

         The following tables present  Tredegar's net sales and operating profit
by segment for the third  quarter and nine months ended  September  30, 1999 and
1998.


                              Net Sales by Segment
                                 (In Thousands)
                                   (Unaudited)


                                             Third Quarter       Nine Months
                                             Ended Sept. 30    Ended Sept. 30
                                          ------------------ -----------------
                                             1999      1998     1999     1998
                                          --------  -------- -------- --------
                                                          
Film Products                             $ 93,548  $ 69,885 $236,567 $215,392
Fiberlux                                     2,620     2,993    7,098    8,598
Aluminum Extrusions                        118,022   112,440  341,141  285,238
Technology:
    Molecumetics                             1,626     1,320    5,391    3,987
    Therics                                     95         -       95        -
    Other                                        -         -        -       29
                                          -------- --------- -------- --------
    Total net sales                       $215,911 $ 186,638 $590,292 $513,244
                                          ======== ========= ======== ========

                           Operating Profit by Segment
                                 (In Thousands)
                                   (Unaudited)

                                              Third Quarter       Nine Months
                                              Ended Sept. 30    Ended Sept. 30
                                           ------------------ -----------------
                                             1999      1998     1999     1998
                                          --------  -------- -------- --------
Film Products:
    Ongoing operations                    $ 16,235 $  12,621 $ 41,783 $ 39,211
    Unusual items                                -         -   (1,170)       -
                                          -------- --------- -------- --------
    Total Film Products                     16,235    12,621   40,613   39,211
                                          -------- --------- -------- --------
Fiberlux                                       160       510       19    1,052
Aluminum Extrusions                         14,107    13,557   42,587   35,150
Technology:
    Molecumetics                            (1,078)     (995)  (2,825)  (2,460)
    Therics                                 (1,746)        -   (3,343)       -
    Venture capital investments             (4,420)     (618)  (6,767)   1,104
    Other                                        -         -        -     (428)
    Unusual items                                -         -   (3,458)     765
                                          -------- --------- -------- --------
      Total technology                      (7,244)   (1,613) (16,393)  (1,019)
                                          -------- --------- -------- --------
Total operating profit                      23,258    25,075   66,826   74,394
Interest income                                310       218      892    1,962
Interest expense                             3,047       266    4,853      952
Corporate expenses, net *                    1,458       476    4,339    4,361
                                          -------- --------- -------- --------
Income before income taxes                  19,063    24,551   58,526   71,043
Income taxes                                 6,748     8,591   20,723   22,626
                                          -------- --------- -------- --------
Net income from continuing operations     $ 12,315  $ 15,960 $ 37,803 $ 48,417
                                          ======== ========= ======== ========


*   Includes  a  pretax gain of $712 on the sale of corporate real estate in the
    third quarter and nine months ended September 30, 1999.

                                       14



         Selected  historical  and pro  forma  results  for  Film  Products  are
summarized  below (pro forma results assume that the  acquisition of Exxon Films
(see Note 4 on page 7) occurred at the beginning of 1998):

                                  Film Products
             Selected Historical and Pro Forma Financial Information
                                 (In Thousands)

                               Historical         Pro Forma
                            -----------------  ----------------
                              1999     1998      1999     1998
                            -------  --------  ------- --------
Third Quarter
- -------------
Net sales                   $ 93,548  $ 69,885  $93,548  $ 97,236
Operating profit              16,235    12,621   16,235    16,349

First Nine Months
- -----------------
Net sales                    236,567   215,392  279,836   293,118
Operating profit              41,783    39,211   47,125    46,921


         Sales and operating  profit in Film Products were higher in 1999 due to
the  acquisition  of Exxon Films.  Excluding the  acquisition,  sales volume and
operating profit were down due to the adverse effects of:

- -        Higher product development spending
- -        Delays in new product introductions
- -        Weakness in international markets, particularly emerging markets

         Selected  historical and pro forma results for Aluminum  Extrusions are
summarized  below (pro forma results  assume that  acquisitions  in 1998 in this
segment (see Note 4 on page 7) occurred at the beginning of 1998):

                               Aluminum Extrusions
             Selected Historical and Pro Forma Financial Information
                                 (In Thousands)

                               Historical         Pro Forma
                            ------------------  ----------------
                               1999     1998      1999     1998
                            -------- ---------  -------- --------
Third Quarter
- -------------
Net sales                   $118,022 $ 112,440  $118,022 $112,440
Operating profit              14,107    13,557    14,107   13,557

First Nine Months
- -----------------
Net sales                    341,141   285,238   341,141  331,037
Operating profit              42,587    35,150    42,587   36,680


         Sales volume and operating profit in Aluminum  Extrusions  increased in
1999  due to  acquisitions,  strong  demand  for  architectural  and  commercial
extrusions  and a high  percentage of mill finish  product  which  maximized the
utilization of press  capacity.  Operating  results were  adversely  affected by
press  and  furnace  repairs  and  resulting  downtime  at the El  Campo,  Texas
facility,  and expenses and disruption  associated  with the second phase of the
press modernization project at the Newnan,  Georgia plant.  Operating results in
the third quarter were hurt by a lag between selling price increases and rapidly
rising aluminum costs.

                                       15


         Molecumetics operating losses increased during 1999 due to higher costs
to support related  programs.  See Note 4 on page 7 regarding the acquisition of
Therics, and Note 3 on page 6 for additional  information  concerning Tredegar's
technology group.

                         Liquidity and Capital Resources

         Tredegar's  total assets  increased to $738.3  million at September 30,
1999,  from $457.2 million at December 31, 1998, due to the acquisition of Exxon
Films,  higher fixed assets from capital  expenditures in excess of depreciation
and venture capital investments.  Total liabilities  increased to $388.9 million
at September 30, 1999,  from $146.9  million at December 31, 1998, due mainly to
borrowings related to the acquisition of Exxon Films,  capital  expenditures and
venture capital investments.

         Net  cash  provided  by  operating  activities  in  excess  of  capital
expenditures  and dividends  increased to $34.6 million in the first nine months
of 1999  from  $26.5  million  in 1998 due to higher  cash  flow from  operating
activities,  partially  offset by higher  capital  expenditures.  Higher capital
expenditures  in Film  Products are related to the new facility  near  Budapest,
Hungary,  and  machinery  and equipment  purchased  for the  manufacture  of new
products   (breathable  and  elastomeric  films  that  are  partially  replacing
conventional  diaper  backsheet and other diaper  components in order to improve
comfort and fit). The Hungarian  facility,  which is now  operational,  produces
disposable films for hygiene products marketed in Eastern Europe. Higher capital
expenditures   in  Aluminum   Extrusions   relate  to  the  second  phase  of  a
modernization  program at the plant in  Newnan,  Georgia  (the  first  phase was
completed in 1996).

         The reasons  for the  decrease  in cash and cash  equivalents  to $19.4
million at September  30,  1999,  from $25.4  million at December 31, 1998,  are
summarized below:



                                                                  Nine Months
                                                                Ended Sept. 30
                                                             -------------------
                                                               1999     1998
                                                             --------  ---------
                                                                 
Cash and cash equivalents, beginning of period               $ 25,409  $120,065
Cash provided by operating activities in excess of
    capital expenditures and dividends                         34,602    26,535
Proceeds from the exercise of stock options                     3,079     3,824
Net increase (decrease) in borrowings                         225,000    (5,000)
Acquisitions                                                 (215,227)  (60,883)
Repurchases of Tredegar common stock                                -   (36,460)
New venture capital investments, net of proceeds
    from disposals                                            (53,493)  (24,202)
Other, net                                                         64      (592)
                                                            ---------  --------
Net increase (decrease) in cash and cash equivalents           (5,975)  (96,778)
                                                            ---------  --------
Cash and cash equivalents, end of period                    $  19,434  $ 23,287
                                                            =========  ========


                                       16



           Quantitative and Qualitative Disclosures About Market Risk

         Tredegar has exposure to the volatility of interest rates, polyethylene
and  polypropylene  resin  prices,  aluminum  ingot  and scrap  prices,  foreign
currencies, emerging markets and technology stocks.

           See Note 2 on page 5 regarding  credit  agreements  and interest rate
exposures.

          Changes in resin prices, and the timing of those changes, could have a
significant  impact on profit margins in Film Products;  however,  those changes
are  generally  followed by a  corresponding  change in selling  prices.  Profit
margins in Aluminum  Extrusions are sensitive to  fluctuations in aluminum ingot
and scrap prices but are also generally  followed by a  corresponding  change in
selling  prices;  however,  there is no assurance that higher ingot costs can be
passed along to customers.

         In the normal  course of business,  we enter into  fixed-price  forward
sales  contracts  with certain  customers  for the sale of fixed  quantities  of
aluminum  extrusions at scheduled  intervals.  In order to hedge our exposure to
aluminum price volatility under these fixed-price arrangements,  which generally
have a duration  of not more than 12  months,  we enter  into a  combination  of
forward purchase commitments and futures contracts to acquire aluminum, based on
the scheduled deliveries.

         We sell to customers in foreign markets through our foreign  operations
and through  exports from U.S.  plants.  The percentage of  consolidated  pretax
income earned by geographic  area for the first nine months of 1999 and 1998 are
presented below:

                       Percentage of Consolidated Pretax
                       Income Earned by Geographic Area*

                                            Nine Months
                                          Ended Sept. 30
                                          ----------------
                                           1999        1998
                                          ------      ------
                         United States      57 %        68 %
                         Canada             19           7
                         Europe              9          11
                         Latin America       8           9
                         Asia                7           5
                                          ------      ------
                         Total             100 %       100 %
                                          ======      ======

          *Based on consolidated pretax income from continuing operations
           excluding venture capital activities and unusual items.


         We attempt to match the  pricing  and cost of our  products in the same
currency and generally  view the  volatility of foreign  currencies and emerging
markets,  and the corresponding impact on earnings and cash flow, as part of the
overall  risk of operating  in a global  environment.  Exports from the U.S. are
generally  denominated  in U.S.  dollars.  Our  foreign  operations  in emerging
markets have  agreements  with certain  customers  that index the pricing of our
products to the U.S.  dollar,  the German mark or the euro. Our foreign currency
exposure on income from foreign  operations in Europe  primarily  relates to the
German mark and the euro.  We believe that our  exposure to the Canadian  dollar
has  been  substantially  neutralized  by  the  U.S.  dollar-based  spread  (the
difference  between selling prices and aluminum  costs)  generated from Canadian
casting  operations and exports from Canada to the U.S. The acquisition of Exxon
Films on May 17, 1999,  will increase the proportion of our income earned in the
U.S.

         See Note 3 on page 6 regarding Tredegar's technology group.

                                       17


                     Year 2000 Information Technology Issues0

         The century date compliance  problem,  which is commonly referred to as
the "Year 2000" problem, will affect many computers and other electronic devices
that are not  programmed to properly  recognize  dates  starting with January 1,
2000.  This could result in system  failures or  miscalculations.  The potential
impact of such  failures  include,  among  others,  an  inability  to secure raw
materials,  manufacture  products,  ship  products and be paid for products on a
timely basis.

         Since 1996, we have been actively  planning and  responding to the Year
2000  problem.  Year 2000 reviews have been and will  continue to be made to our
Executive  Committee and senior  management.  Periodic reviews with the Board of
Directors began in August 1998.

         Our Year 2000 compliance efforts are focused on internal computer-based
information systems, external electronic interfaces and communication equipment,
shop  floor  machines  and other  manufacturing  and  research  process  control
devices.  Remediation of systems  requiring  changes was completed at the end of
1998, except for revisions to a small portion of certain software programs,  the
replacement of certain software for the four aluminum  extrusion plants recently
acquired in Canada,  and computer  systems  related to the  acquisition of Exxon
Films discussed below. Remediation efforts for the exceptions have extended into
1999. Testing of systems began in mid-1998 and will continue through 1999. We do
not believe  contingency  plans are necessary for internal systems at this time.
We are also actively  evaluating the Year 2000 capabilities of parties with whom
we  have  key  business  relationships  (suppliers,  customers  and  banks,  for
example). Contingency plans will be developed for these relationships as needed.
Work to fix the  Year  2000  problem  is being  performed  largely  by  internal
personnel and we do not track those costs. The incremental costs associated with
correcting the problem are not expected to have a material adverse effect on our
operating results, financial condition or cash flows.

         The computer hardware,  software systems and  communications  equipment
related to Exxon Films have been replaced and are now Year 2000 compliant.  This
business has been integrated into the enterprise-wide  systems infrastructure of
Tredegar Film  Products.  We estimate that the cost of all  remediation  efforts
related to Exxon Films is  approximately  $1.9  million,  most of which is being
capitalized and amortized over the estimated useful life of related assets.

         While we believe that we are taking the necessary  steps to resolve our
Year 2000 issues in a timely  manner,  there can be no assurance that there will
be no Year 2000 problems. If any such problems occur, we will work to solve them
as quickly as possible. At present, we do not expect that any such problems will
have a material  adverse effect on our businesses.  The failure,  however,  of a
major  customer  or  supplier  to be Year  2000-compliant  could have a material
adverse effect on our businesses.

                                       18



                            New Accounting Standards

         The  Financial  Accounting  Standards  Board has issued a new  standard
affecting the accounting for derivative instruments and hedging activities. This
standard  is  not  expected  to  significantly  change  our  operating  results,
financial  condition or  disclosures.  The new  standard  will be adopted in the
first quarter of 2001.

                                       19




PART II -         OTHER INFORMATION


Item 6.           Exhibits and Reports on Form 8-K.

     (a)          Exhibit No.

                  4     Credit Agreement, dated October 13, 1999, among Tredegar
                        Corporation, the banks named therein, Bank  of  America,
                        N.A.  as  Administrative Agent, The Bank of New York and
                        Crestar Bank as Co-Documentation Agents

                  27    Financial Data Schedule

     (b)          Reports on Form 8-K.  No  reports on  Form  8-K were filed for
                  the quarter ended September 30, 1999.


                                       20





                                   SIGNATURES

         Pursuant to the  requirements  of the Securities  Exchange Act of 1934,
the  Registrant  has duly  caused  this report to be signed on its behalf by the
undersigned thereunto duly authorized.

                                    Tredegar Corporation
                                    (Registrant)



Date:  November 12, 1999            /s/ N. A. Scher
       -------------------------    --------------------------------------------
                                    Norman A. Scher
                                    Executive Vice President and
                                    Chief Financial Officer
                                    (Principal Financial Officer)

Date:  November 12, 1999            /s/ D. Andrew Edwards
       -------------------------    --------------------------------------------
                                    D. Andrew Edwards
                                    Vice President, Treasurer and Controller
                                    (Principal Accounting Officer)



                                       21




                                  EXHIBIT INDEX


Exhibit No.    Description

      4        Credit   Agreement,  dated  October  13,  1999,  among   Tredegar
               Corporation,  the  banks  named therein, Bank of America, N.A. as
               Administrative  Agent, The  Bank  of New York and Crestar Bank as
               Co-Documentation Agents

      27       Financial Data Schedule